Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS

Bone Marrow Transplant. 2016 Jul;51(7):991-3. doi: 10.1038/bmt.2016.23. Epub 2016 Feb 29.

P B Dahi^{1

2}, E Morawa^{1

2}, M-A Perales^{1

2}, E C Zabor³, S M Devlin³, M Maloy¹, H Castro-Malaspina^{1

2}, R J O'Reilly^{2

4}, E B Papadopoulos^{1

2}, A A Jakubowski^{1

2}, S A Giralt^{1

2}

¹ Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Weill Cornell Medical College, New York, NY, USA.
³ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Pediatric Bone Marrow Transplant Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

No abstract available

MeSH terms